Trials / Completed
CompletedNCT04286581
Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 148 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.
Detailed description
Patients who are scheduled for elective ambulatory surgery under general anesthesia will be randomized to one of two groups. Group 1 will receive an I-gel laryngeal mask airway (LMA) and group 2 will receive an Ambu Auragain LMA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | I-Gel Laryngeal Mask Airway | The I-Gel Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness. |
| DEVICE | Ambu Auragain Laryngeal Mask Airway | The Ambu Auragain Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness. |
Timeline
- Start date
- 2021-03-22
- Primary completion
- 2021-10-31
- Completion
- 2021-10-31
- First posted
- 2020-02-27
- Last updated
- 2022-12-19
- Results posted
- 2022-12-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04286581. Inclusion in this directory is not an endorsement.